Related Experiment Video
Updated: Jul 15, 2026
12:30
Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
Published on: August 12, 2014
Vectors for airway gene delivery.
Pamela B Davis1, Mark J Cooper
1Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. pamela.davis@case.edu
The AAPS Journal
|April 6, 2007
Summary
Gene therapy for airway epithelium faces challenges. Nonviral methods like lipid-mediated transfer and DNA nanoparticles show promise for cystic fibrosis, with ongoing research to improve safety and expression duration.
Area of Science:
- Gene therapy
- Airway epithelium
- Nanomedicine
Background:
- Airway epithelium is accessible for gene delivery.
- Gene therapy faces significant challenges beyond initial accessibility.
- Nonviral gene transfer systems offer potential for repeated dosing and long-term expression.
Purpose of the Study:
- Review advances in nonviral gene transfer for airway epithelium.
- Evaluate lipid-mediated gene transfer and DNA nanoparticles for therapeutic applications.
- Discuss strategies to overcome toxicity and short expression duration.
Main Methods:
- Clinical trial data analysis of lipid-mediated gene transfer.
- Assessment of DNA nanoparticles for gene delivery.
- Review of cellular uptake and expression mechanisms.
Main Results:
- Both lipid-mediated transfer and DNA nanoparticles show efficiency for cystic fibrosis gene correction.
- First-generation systems exhibit inflammatory toxicity and short expression duration.
- Engineering adjustments can mitigate toxicity and prolong expression.
Conclusions:
- Nonviral gene transfer systems are viable candidates for airway diseases like cystic fibrosis.
- Further research is needed to optimize lipid formulations, CpG content, and plasmid DNA for enhanced safety and efficacy.
- Advances in understanding cellular interactions are crucial for clinical translation.
